Integration of nanoparticle delivery systems advances targeted therapeutics for cardiovascular diseases, suggesting potential benefits of traditional medicine.
Despite these promising advances, significant challenges remain that hinder clinical translation, including the inherent complexity of multi-component TCM formulations, unresolved nanosafety concerns, lack of standardization in both herbal extracts and nano-formulations, and substantial hurdles in industrial scalability and regulatory approval. By integrating the holistic principles of TCM with the precision of nanotechnology, this evolving field holds immense promise for developing next-generation, targeted therapeutics for cardiovascular diseases, bridging the gap between traditional medicine and modern drug delivery paradigms.
No takes yet. Share an insight, caveat, or question.
熊晏樱 et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: